Trevena announced collaboration with Imperial College London to evaluate TRV027 in COVID-19 patients
On Jun. 2, 2020, Trevena announced it had entered into a collaboration with Imperial College London to evaluate…
-
-
NIH reported early results show benefit of remdesivir for COVID-19
On Jun. 2, 2020, the National Institutes of Health (NIH) reported that early results showed that remdesivir benefited…
-
FDA cleared IND for iNKT Cells to treat COVID-19 patients
On Jun. 2, 2020, Agenus announced the U.S. Food and Drug Administration’s (FDA) clearance of AgenTus’ IND application…
-
The USDA announced the first confirmed case of a dog in the U.S. to test positive for SARS-CoV-2
On Jun. 2, 2020, The U.S. Department of Agriculture’s (USDA) National Veterinary Services Laboratories announced that it found…
-
Resverlogix announced COVID-19 clinical trial program launch
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetalone’s…
-
Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
-
Anixa Biosciences and OntoChem synthesized four potential Covid-19 drugs for testing in biological assays
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced that the Company, together with partner OntoChem GmbH, has…
-
Proteostasis Therapeutics announced in vitro data for PTI-129 as potential treatment candidate for COVID-19
On Jun. 1, 2020, Proteostasis Therapeutics announced results from in vitro studies evaluating the use of PTI-129 as…
-
FDA issued Emergency Use Authorization for Impella RP as therapy for COVID-19 patients with right heart failure
On Jun. 1, 2020, the Food and Drug Administration (FDA) announced it had issued an emergency use authorization…
-
Altimmune launched clinical trial of T-COVIDTM, an investigational intranasal immune modulator for treatment of patients with early COVID-19
On Jun. 1, 2020, Altimmune announced the U.S. Food and Drug Administration (FDA) had authorized the Company to…
-
LabCorp launched new COVID-19 clinical trial site to connect patients with U.S. research trials
On Jun. 1, 2020, LabCorp announced that Covance, its drug development business, had created COVID-19 Clinical Trial Connect…
-
FDA authorized OPKO Health clinical trial evaluating RAYALDEE in COVID-19 patients
On Jun. 1, 2020, OPKO Health announced the U.S. Food and Drug Administration (FDA) had authorized OPKO to…
-
Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be Manufacturing partner for COVID-19 vaccine candidate TNX-1800
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
-
Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
On May 31, 2020, Cytiva announced their Fast Trak process development team will use their expertise to develop…
-
Moderna announced first participants in each age cohort dosed in phase 2 study of mRNA vaccine against novel Coronavirus
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
-
The US Dept of Defense launched effort to collect COVID-19 convalescent plasma
On May 29, 2020, U.S. Department of Defense (DoD) announced it had begun an effort to collect 8,000…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine | WHO
International community rallied to support open research and science to fight COVID-19
On May 29, 2020, the World Health Organization (WHO) announced that thirty countries and multiple international partners and…
-
The FDA streamlined development of tests with at-home sample collection
On May 29, 2020, the U.S. Food and Drug Administration (FDA) took steps to further support the development…
-
Oxford Foundry announced four new innovations for COVID-19 recovery
On May 29, 2020, the Oxford Foundry announced support of four new innovative solutions for the OXFO COVID-19…
-
CIRM board approved three projects targeting COVID-19
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs…
-
The US Dept of Veterans Affairs conducted deep-dive study into effects of COVID-19 on Veterans
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
-
FDA authorized Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for emergency use
On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the U.S. Food…
-
Roche initiated phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On May 28, 2020, Roche announced it had initiated of a global phase III, randomised, double-blind, multicentre study…
-
Atossa Therapeutics announced second COVID-19 therapeutic development program, AT-301 nasal spray
On May 28, 2020, Atossa Therapeutics announced that it had begun the development of a second COVID-19 program…
-
Quest Diagnostics launched COVID-19 workforce testing services to help organizations in fostering safer workplaces
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
-
Philips launched next generation wearable biosensor for early patient deterioration detection for COVID-19
On May 26, 2020, Royal Philips announced it had received 510(k) clearance from the FDA for its wearable…
-
GenScript announced CE-IVD for neutralizing antibody test kit of SARS-CoV-2 and COVID-19 diagnostics
On May 26, 2020, GenScript Biotech announced that it had obtained CE-IVD for its SARS-CoV-2 diagnostic products to…
-
Merck and Ridgeback Bio announced collaboration to advance development of novel antiviral candidate, EIDD-2801
On May 26, 2020, Merck and and and Ridgeback Biotherapeutics announced a collaboration agreement to develop EIDD-2801, an…
-
Innovation Pharma receives data from public health research institute showing brilacidin inhibits SARS-CoV-2 (COVID-19) in human cell line
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
-
Cerecor and Myriad Genetics announced levels of novel cytokine, LIGHT highly correlated with disease severity and mortality in COVID-19 ARDS biomarker study
Cerecor and Myriad Genetics announced that levels of novel cytokine, LIGHT, were highly correlated with disease severity and…
